MCTIC
GILD icon

MacGuire Cheswick & Tuttle Investment Counsel’s Gilead Sciences GILD Stock Holding History

MacGuire Cheswick & Tuttle Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$1.12M Sell
17,891
-1,650
-8% -$115K 0.23% 59
2018
Q3 		$1.51M Sell
19,541
-3,085
-14% -$233K 0.26% 59
2018
Q2 		$1.6M Sell
22,626
-1,000
-4% -$70.6K 0.29% 58
2018
Q1 		$1.78M Sell
23,626
-3,100
-12% -$246K 0.33% 57
2017
Q4 		$1.92M Sell
26,726
-6,812
-20% -$517K 0.35% 55
2017
Q3 		$2.72M Sell
33,538
-70,183
-68% -$5.37M 0.53% 47
2017
Q2 		$7.34M Sell
103,721
-16,845
-14% -$1.12M 1.49% 28
2017
Q1 		$8.19M Sell
120,566
-7,785
-6% -$547K 1.59% 26
2016
Q4 		$9.19M Buy
128,351
+775
+0.6% +$57.6K 1.89% 22
2016
Q3 		$10.1M Sell
127,576
-15,069
-11% -$1.22M 2.26% 18
2016
Q2 		$11.9M Sell
142,645
-3,380
-2% -$300K 2.65% 14
2016
Q1 		$13.4M Sell
146,025
-130
-0.1% -$11.7K 3.12% 11
2015
Q4 		$14.8M Buy
146,155
+1,365
+0.9% +$142K 3.32% 7
2015
Q3 		$14.2M Buy
144,790
+1,385
+1% +$154K 3.48% 6
2015
Q2 		$16.8M Sell
143,405
-2,902
-2% -$317K 3.75% 4
2015
Q1 		$14.4M Sell
146,307
-3,224
-2% -$327K 3.24% 5
2014
Q4 		$14.1M Sell
149,531
-3,570
-2% -$369K 3.16% 5
2014
Q3 		$16.3M Buy
153,101
+2,352
+2% +$230K 3.8% 3
2014
Q2 		$12.5M Sell
150,749
-1,770
-1% -$138K 2.9% 10
2014
Q1 		$10.8M Buy
152,519
+4,065
+3% +$319K 2.62% 12
2013
Q4 		$11.1M Buy
148,454
+1,430
+1% +$99.6K 2.69% 11
2013
Q3 		$9.24M Buy
147,024
+834
+0.6% +$49.8K 2.54% 13
2013
Q2 		$7.5M Buy
+146,190
New +$7.62M 2.15% 18

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

MacGuire Cheswick & Tuttle Investment Counsel's GILD Position: Q4 2018 in Review

MacGuire Cheswick & Tuttle Investment Counsel reduced its Gilead Sciences (GILD) stake by 8.4% in Q4 2018, selling an estimated $115K and leaving 17,891 shares worth $1.12M. The position accounts for 0.23% of the portfolio, ranked #59.

MacGuire Cheswick & Tuttle Investment Counsel first reported a position in GILD in Q2 2013 and has held it in 23 quarters since. The position peaked at $16.8M in Q2 2015. 1,497 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • MacGuire Cheswick & Tuttle Investment Counsel held 17,891 shares of Gilead Sciences worth $1.12M as of Q4 2018.
  • MacGuire Cheswick & Tuttle Investment Counsel sold 1,650 Gilead Sciences shares in Q4 2018, an estimated $115K.
  • Gilead Sciences made up 0.23% of MacGuire Cheswick & Tuttle Investment Counsel's portfolio in Q4 2018, its #59 holding.
  • MacGuire Cheswick & Tuttle Investment Counsel first reported a position in Gilead Sciences in Q2 2013 and has held it in 23 quarters since.
  • MacGuire Cheswick & Tuttle Investment Counsel's Gilead Sciences position peaked at $16.8M in Q2 2015.
  • 1,497 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on MacGuire Cheswick & Tuttle Investment Counsel's 13F filing for Q4 2018, filed 11 Feb 2019.